AstraZeneca and Amgen’s Tezspire (tezepelumab) has received a positive opinion [...]

Affibody has reported positive 16-week data from a global Phase [...]

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) has acquired worldwide rights [...]

Johnson & Johnson has reported new data from the Phase [...]

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

Arkivum has announced a partnership with PHARMASEAL, provider of the [...]

Formation Bio, the AI-native pharmaceutical company advancing a new model [...]

Kairos Pharma has announced encouraging interim efficacy results from its [...]

Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

Terumo Blood and Cell Technologies has announced regulatory approvals for [...]